Growing community of inventors

Bellaterra, Spain

Fàtima Bosch I Tubert

Average Co-Inventor Count = 6.43

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Fàtima Bosch I TubertMaria Bobadilla (2 patents)Fàtima Bosch I TubertMaria Antonia Blasco Marhuenda (2 patents)Fàtima Bosch I TubertIvan Formentini (2 patents)Fàtima Bosch I TubertChristian Baer (2 patents)Fàtima Bosch I TubertJacques Mizrahi (1 patent)Fàtima Bosch I TubertRosa María Serrano Ruiz (1 patent)Fàtima Bosch I TubertBruno Bernardes De Jesus (1 patent)Fàtima Bosch I TubertEduard Ayuso (1 patent)Fàtima Bosch I TubertIvan Formentini (0 patent)Fàtima Bosch I TubertChristian Baer (0 patent)Fàtima Bosch I TubertBruno Bernardes De Jesus (0 patent)Fàtima Bosch I TubertFàtima Bosch I Tubert (2 patents)Maria BobadillaMaria Bobadilla (3 patents)Maria Antonia Blasco MarhuendaMaria Antonia Blasco Marhuenda (3 patents)Ivan FormentiniIvan Formentini (3 patents)Christian BaerChristian Baer (2 patents)Jacques MizrahiJacques Mizrahi (1 patent)Rosa María Serrano RuizRosa María Serrano Ruiz (1 patent)Bruno Bernardes De JesusBruno Bernardes De Jesus (1 patent)Eduard AyusoEduard Ayuso (1 patent)Ivan FormentiniIvan Formentini (0 patent)Christian BaerChristian Baer (0 patent)Bruno Bernardes De JesusBruno Bernardes De Jesus (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Universität Autonoma De Barcelona (2 from 45 patents)

2. Fundación Del Sector Público Estatal Centro Nacional De Investigaciones Oncologicas Carlos III (f.s.p. Cnio) (1 from 4 patents)

3. Fundación Del Sector Público Estatal Centro Nacional Dl'investigaciones Oncológicas Carlos III (f.s.p. Cnio) (1 from 1 patent)

4. Fundacion Centro Nacional De Investigaciones Oncologicas Carlos III (6 patents)


2 patents:

1. 11529396 - Telomerase reverse transcriptase-based therapies

2. 11261434 - Telomerase reverse transcriptase-based therapies for treatment of conditions associated with myocardial infarction

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/19/2025
Loading…